Neuroscience-Informed Treatments
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391:1683–1692Crossref, Google Scholar
:Transcranial direct current stimulation in the acute depressive episode: a systematic review of current knowledge. J ECT 2018; 34:153–163Crossref, Google Scholar
:Canuso CM, Singh JB, Fedgchin M, et al: Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry 2018; 175:620–630Google Scholar
Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry 2018; 75:1081–1087Crossref, Google Scholar
:Gandal MJ, Haney JR, Parikshak NN, et al: Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 2018; 359:693–697Google Scholar
Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? J Affect Disord 2018; 244:100–106Crossref, Google Scholar
:Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 2018; 175:327–335Crossref, Google Scholar
:International randomized-controlled trial of transcranial direct current stimulation in depression. Brain Stimul 2018; 11:125–133Crossref, Google Scholar
:Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: an individual patient data meta-analysis of randomised, sham-controlled trials. Neurosci Biobehav Rev 2018; 90:137–145Crossref, Google Scholar
:Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev 2018; 95:61–72Crossref, Google Scholar
:Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 2018; 79:35–48Crossref, Google Scholar
:Transcranial direct current stimulation in psychiatric disorders: a comprehensive review. Psychiatr Clin North Am 2018; 41:447–463Crossref, Google Scholar
:Ketamine: quo vadis? Am J Psychiatry 2018; 175:297–299Crossref, Google Scholar
:Imaging genetics paradigms in depression research: systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2018; 86:102–113Crossref, Google Scholar
:Ryan KM, McLoughlin DM: From molecules to mind: mechanisms of action of electroconvulsive therapy. Acta Psychiatr Scand 2018; 138:177–179Google Scholar
Ketamine: a review for clinicians. Focus 2018; 16:243–250Link, Google Scholar
:Lost in translation: traversing the complex path from genomics to therapeutics in autism spectrum disorder. Neuron 2018; 100:406–423Crossref, Google Scholar
:Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 2018; 5:65–78Crossref, Google Scholar
:Functional neuroimaging evidence for distinct neurobiological pathways in attention-deficit/hyperactivity disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2018; 3:675–685Crossref, Google Scholar
:Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression. J Affect Disord 2018; 232:143–151Crossref, Google Scholar
:Using fMRI and machine learning to predict symptom improvement following cognitive behavioural therapy for psychosis. Neuroimage Clin 2018; 20:1053–1061Crossref, Google Scholar
:Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry 2018; 175:729–740Crossref, Google Scholar
:Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol 2017; 128:1774–1809Crossref, Google Scholar
:Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med 2017; 376:2523–2533Crossref, Google Scholar
:Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23:28–38Crossref, Google Scholar
:An integrated neuroscience perspective on formulation and treatment planning for posttraumatic stress disorder: an educational review. JAMA Psychiatry 2017; 74:407–415Crossref, Google Scholar
:Low-intensity transcranial current stimulation in psychiatry. Am J Psychiatry 2017; 174:628–639Crossref, Google Scholar
:A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74:399–405Crossref, Google Scholar
:Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 2014; 58:161–166Crossref, Google Scholar
:Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351–354Crossref, Google Scholar
:Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul 2016; 9:641–661Crossref, Google Scholar
:The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013; 70:383–391Crossref, Google Scholar
:A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67:793–802Crossref, Google Scholar
:The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 2009; 66:886–897Crossref, Google Scholar
:Electroconvulsive therapy’s mechanism of action: neuroendocrine hypotheses. J ECT 2014; 30:107–110Crossref, Google Scholar
:Psychiatry as a clinical neuroscience discipline. JAMA 2005; 294:2221–2224Crossref, Google Scholar
:Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology 2013; 38:2467–2474Crossref, Google Scholar
:ECT in treatment-resistant depression. Am J Psychiatry 2012; 169:1238–1244Crossref, Google Scholar
:Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63:1337–1344Crossref, Google Scholar
:Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008; 193:152–155Crossref, Google Scholar
:Emphasizing malleability in the biology of depression: durable effects on perceived agency and prognostic pessimism. Behav Res Ther 2015; 71:125–130Crossref, Google Scholar
:Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939–1945Crossref, Google Scholar
:Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28:1852–1865Crossref, Google Scholar
:Petrides G, Malur C, Braga RJ, et al: Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. Am J Psychiatry 2015; 172:52–58Google Scholar
Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68:568–577Crossref, Google Scholar
:Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996; 29:23–26Crossref, Google Scholar
:NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016; 533:481–486Crossref, Google Scholar
:A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856–864Crossref, Google Scholar
: